These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26224606)

  • 1. Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free mice.
    Pedroso SHSP; Vieira AT; Bastos RW; Oliveira JS; Cartelle CT; Arantes RME; Soares PMG; Generoso SV; Cardoso VN; Teixeira MM; Nicoli JR; Martins FS
    Microbiology (Reading); 2015 Oct; 161(10):1950-1960. PubMed ID: 26224606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydrotanshinone attenuates chemotherapy-induced intestinal mucositis and alters fecal microbiota in mice.
    Wang L; Wang R; Wei GY; Wang SM; Du GH
    Biomed Pharmacother; 2020 Aug; 128():110262. PubMed ID: 32447214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile.
    Stringer AM; Gibson RJ; Bowen JM; Logan RM; Ashton K; Yeoh AS; Al-Dasooqi N; Keefe DM
    Int J Exp Pathol; 2009 Oct; 90(5):489-99. PubMed ID: 19765103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophil plays a crucial role in intestinal mucositis induced by antineoplastic chemotherapy.
    Arifa RDN; Brito CB; de Paula TP; Lima RL; Menezes-Garcia Z; Cassini-Vieira P; Vilas Boas FA; Queiroz-Junior CM; da Silva JM; da Silva TA; Barcelos LS; Fagundes CT; Teixeira MM; Souza DG
    Immunology; 2022 Mar; 165(3):355-368. PubMed ID: 34964126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reduction of oxidative stress by nanocomposite Fullerol decreases mucositis severity and reverts leukopenia induced by Irinotecan.
    Arifa RDN; Paula TP; Madeira MFM; Lima RL; Garcia ZM; Ÿvila TV; Pinho V; Barcelos LS; Pinheiro MVB; Ladeira LO; Krambrock K; Teixeira MM; Souza DG
    Pharmacol Res; 2016 May; 107():102-110. PubMed ID: 26987941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation.
    Lima-Júnior RC; Figueiredo AA; Freitas HC; Melo ML; Wong DV; Leite CA; Medeiros RP; Marques-Neto RD; Vale ML; Brito GA; Oriá RB; Souza MH; Cunha FQ; Ribeiro RA
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):931-42. PubMed ID: 22101361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saccharomyces cerevisiae UFMG A-905 treatment reduces intestinal damage in a murine model of irinotecan-induced mucositis.
    Bastos RW; Pedroso SH; Vieira AT; Moreira LM; França CS; Cartelle CT; Arantes RM; Generoso SV; Cardoso VN; Neves MJ; Nicoli JR; Martins FS
    Benef Microbes; 2016 Sep; 7(4):549-57. PubMed ID: 27133563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new animal model of intestinal mucositis induced by the combination of irinotecan and 5-fluorouracil in mice.
    Pereira VB; Melo AT; Assis-Júnior EM; Wong DV; Brito GA; Almeida PR; Ribeiro RA; Lima-Júnior RC
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):323-32. PubMed ID: 26666645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irinotecan-induced mucositis: the interactions and potential role of GLP-2 analogues.
    Mayo BJ; Stringer AM; Bowen JM; Bateman EH; Keefe DM
    Cancer Chemother Pharmacol; 2017 Feb; 79(2):233-249. PubMed ID: 27770239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis.
    Logan RM; Gibson RJ; Bowen JM; Stringer AM; Sonis ST; Keefe DM
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):33-41. PubMed ID: 17703303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pogostemon cablin (Blanco) Benth granule revealed a positive effect on improving intestinal barrier function and fecal microbiota in mice with irinotecan-induced intestinal mucositis.
    Li P; Xiao X; Gong J; Zhang X; Cai K; Liang R; Wang D; Chen Y; Chen H; Xie Z; Liao Q
    Arch Microbiol; 2023 Apr; 205(5):179. PubMed ID: 37029820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colonization by
    Menezes-Garcia Z; Do Nascimento Arifa RD; Acúrcio L; Brito CB; Gouvea JO; Lima RL; Bastos RW; Fialho Dias AC; Antunes Dourado LP; Bastos LFS; Queiroz-Júnior CM; Igídio CED; Bezerra RO; Vieira LQ; Nicoli JR; Teixeira MM; Fagundes CT; Souza DG
    Gut Microbes; 2020 Nov; 11(6):1531-1546. PubMed ID: 32573321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives.
    Ribeiro RA; Wanderley CW; Wong DV; Mota JM; Leite CA; Souza MH; Cunha FQ; Lima-Júnior RC
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):881-893. PubMed ID: 27590709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carvacryl acetate, a novel semisynthetic monoterpene ester, binds to the TRPA1 receptor and is effective in attenuating irinotecan-induced intestinal mucositis in mice.
    Alvarenga EM; Sousa NA; de Araújo S; Júnior JLP; Araújo AR; Iles B; Pacífico DM; Brito GAC; Souza EP; Sousa DP; Medeiros JVR
    J Pharm Pharmacol; 2017 Dec; 69(12):1773-1785. PubMed ID: 28940490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bifidobacterium longum subsp. longum 5
    Quintanilha MF; Miranda VC; Souza RO; Gallotti B; Cruz C; Santos EA; Alvarez-Leite JI; Jesus LCL; Azevedo V; Trindade LM; Cardoso VN; Ferreira E; Carvalho BA; Soares PMG; Vieira AT; Nicoli JR; Martins FS
    Life Sci; 2022 Jan; 289():120243. PubMed ID: 34922941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats.
    Stringer AM; Gibson RJ; Logan RM; Bowen JM; Yeoh AS; Keefe DM
    Cancer Biol Ther; 2008 Dec; 7(12):1919-25. PubMed ID: 18927500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum-derived bovine immunoglobulin/protein isolate in the alleviation of chemotherapy-induced mucositis.
    Bateman E; Weaver E; Klein G; Wignall A; Wozniak B; Plews E; Mayo B; White I; Keefe D
    Support Care Cancer; 2016 Jan; 24(1):377-385. PubMed ID: 26081596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A More Robust Gut Microbiota in Calorie-Restricted Mice Is Associated with Attenuated Intestinal Injury Caused by the Chemotherapy Drug Cyclophosphamide.
    Liu T; Wu Y; Wang L; Pang X; Zhao L; Yuan H; Zhang C
    mBio; 2019 Mar; 10(2):. PubMed ID: 30862756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irinotecan-induced intestinal mucositis in mice: a histopathological study.
    Boeing T; Gois MB; de Souza P; Somensi LB; Sant Ana DMG; da Silva LM
    Cancer Chemother Pharmacol; 2021 Mar; 87(3):327-336. PubMed ID: 33130913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted inhibition of IL-18 attenuates irinotecan-induced intestinal mucositis in mice.
    Lima-Júnior RC; Freitas HC; Wong DV; Wanderley CW; Nunes LG; Leite LL; Miranda SP; Souza MH; Brito GA; Magalhães PJ; Teixeira MM; Cunha FQ; Ribeiro RA
    Br J Pharmacol; 2014 May; 171(9):2335-50. PubMed ID: 24428790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.